Technology News and Research

RSS

Matrix Medical Network announces acquisition of Ascender

Matrix Medical Network, a national leader in prospective medical assessment services, announced today that it has acquired Ascender, a leading provider of integrated, advanced information technology to healthcare clients, in an all-cash transaction.

28 Aug 2012

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Depomed, Inc. today announced that Janssen Pharmaceuticals, Inc., has licensed rights to Depomed's Acuform gastric retentive drug delivery technology.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

Virtua achieves significant clinical milestone in the adoption of electronic health records

Today, Siemens Healthcare has announced that Virtua, a multi-hospital healthcare system, has achieved a significant clinical milestone in the adoption of electronic health records.

27 Aug 2012

BioTime amends license agreement with University of Utah for HyStem technology

BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.

27 Aug 2012

Tris Pharma joins Perrigo to launch first ever store brand ER liquid cough/cold product

Perrigo Company and Tris Pharma, Inc. today announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym extended–release oral liquid suspension containing dextromethorphan polistirex and will be marketed under major U.S. retailer and wholesalers' store brands or own label brands.

27 Aug 2012

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.

27 Aug 2012

Bode launches Rapid DNA Service to provide near real-time analysis

The Bode Technology Group, Inc. (Bode), a leading provider of innovative forensic DNA services, announced today the launch of their Rapid DNA Service to provide near real-time DNA analysis.

27 Aug 2012

BD announces acquisition of Sirigen

BD, a leading global medical technology company, announced today that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies.

From BD (Becton, Dickinson and Company) 27 Aug 2012

Additional data from Auxilium XIAFLEX phase III studies on Peyronie's disease

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced that additional data will be presented from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).

27 Aug 2012

FDA approves Mallinckrodt's EXALGO (32 mg) sNDA to manage opioid-related pain

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

27 Aug 2012

New method helps engineer tissues with embedded nanoscale networks

A multi-institutional research team has developed a method for embedding networks of biocompatible nanoscale wires within engineered tissues. These networks—which mark the first time that electronics and tissue have been truly merged in 3D—allow direct tissue sensing and potentially stimulation, a potential boon for development of engineered tissues that incorporate capabilities for monitoring and stimulation, and of devices for screening new drugs.

27 Aug 2012

Baylor Plano first hospital to merge MEM software and Epoch platform for atrial fibrillation therapy

Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.

27 Aug 2012

New device can measure mass of individual molecules one at a time

A team led by scientists at the California Institute of Technology (Caltech) have made the first-ever mechanical device that can measure the mass of individual molecules one at a time.

27 Aug 2012

Results from Roche's trastuzumab emtansine Phase III trial on HER2-positive breast cancer

ImmunoGen, Inc., a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a significant improvement in OS compared to those randomized to standard-of-care therapy.

27 Aug 2012

$Noninvasive fractional flow reserve superior to CT in identifying individuals with ischemia$

Noninvasive fractional flow reserve superior to CT in identifying individuals with ischemia

Among patients with suspected or known coronary artery disease, use of a method that applies computational fluid dynamics to derive certain data from computed tomographic (CT) angiography demonstrated improved diagnostic accuracy vs. CT angiography alone for the diagnosis of ischemia, according to a study being published online by JAMA.

27 Aug 2012

Loyola University Medical Center named among Most Wired Hospitals and Health Systems

Loyola University Medical Center (LUMC) has been named one of the nation's Most Wired Hospitals and Health Systems, according to results of the 2012 Most Wired Survey and Benchmarking Study.

27 Aug 2012

New non-invasive brain scan can benefit patients with epileptic seizures

A team of University of Minnesota biomedical engineers and researchers from Mayo Clinic published a groundbreaking study today that outlines how a new type of non-invasive brain scan taken immediately after a seizure gives additional insight into possible causes and treatments for epilepsy patients.

27 Aug 2012

Detect-to-Protect project to measure performance of new sensors for biological agents

The idea that disease and infection might be used as weapons is truly dreadful, but there is plenty of evidence showing that biological weapons have been around since ancient times. Bioterrorism, as it is dubbed, is nothing new, and although medicines have made the world a safer place against a myriad of old scourges both natural and manmade, it still remains all too easy today to uncork a nasty cloud of germs.

27 Aug 2012

HHS softens stage 2 meaningful use standards for electronic health records

In other health information technology news, the American Hospital Association has suggested modifications to Federal Communication Commission's Rural Health Care Pilot Program.

27 Aug 2012

Technology News and Research

Matrix Medical Network announces acquisition of Ascender

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Virtua achieves significant clinical milestone in the adoption of electronic health records

BioTime amends license agreement with University of Utah for HyStem technology

Tris Pharma joins Perrigo to launch first ever store brand ER liquid cough/cold product

Mallinckrodt receives FDA approval for 32 mg tablet strength of EXALGO

Bode launches Rapid DNA Service to provide near real-time analysis

BD announces acquisition of Sirigen

Additional data from Auxilium XIAFLEX phase III studies on Peyronie's disease

FDA approves Mallinckrodt's EXALGO (32 mg) sNDA to manage opioid-related pain

New method helps engineer tissues with embedded nanoscale networks

Baylor Plano first hospital to merge MEM software and Epoch platform for atrial fibrillation therapy

New device can measure mass of individual molecules one at a time

Results from Roche's trastuzumab emtansine Phase III trial on HER2-positive breast cancer

Noninvasive fractional flow reserve superior to CT in identifying individuals with ischemia

Loyola University Medical Center named among Most Wired Hospitals and Health Systems

New non-invasive brain scan can benefit patients with epileptic seizures

Detect-to-Protect project to measure performance of new sensors for biological agents

HHS softens stage 2 meaningful use standards for electronic health records

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News